Patent Assignment
Reel/Frame 010764/0417
Assignment of Assignor's Interest
Recorded: 2000-04-17
Pages: 2
Assignee
CALYDON, INC.
1324 CHESAPEAKE TERRACE, SUNNYVALE, CALIFORNIA, 94089
Covered Property
(1)
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Patent:
6,495,130 →
Application:
09/474,699 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Apr 10, 2001
From: CALYDON, INC.
To: PERSEUS CAPITAL, L.L.C.
Reel/Frame 011648/0035 →
Assignment of Assignor's Interest
Dec 17, 2001
From: CALYDON, INC
To: CELL GENESYS, INC
Reel/Frame 012243/0012 →
Assignment of Assignor's Interest
Feb 2, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023973/0005 →
Assignment of Assignor's Interest
Dec 27, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025568/0888 →
Acceptance of Patent Rights
Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026180/0885 →
Change of Name
Nov 9, 2020
From: COLD GENESYS, INC.
To: CG ONCOLOGY, INC.
Reel/Frame 054362/0411 →